Diagnosis typically involves gastric emptying studies, where patients consume a meal containing a small amount of radioactive material, and imaging tracks how quickly the stomach empties
This mechanism of action is more aligned with the bodys natural processes, making it a more sustainable option for weight loss
This clearance process operates on a 12-week window, meaning visual changes are not immediate
3.1.2 Other PEDs This group included other substances prohibited by WADA, such as non-approved substances (BPC-157) from Section S0, other anabolic agents (clenbuterol and SARMs) from Subsection S0, S1.2, peptide hormones and their releasing factors (AOD-9604, hGH 176-191, CJC-1295, ibutamoren, ipamorelin, and growth hormone-releasing peptide) from S2.2, growth factors and growth factor modulators (thymosin-4 and its derivative TB-500) from S2.3, beta-2 agonists (salbutamol and indacaterol) from S3, metabolic modulators (meldonium, GW1516, SR9009, SR9011, and insulins) from Section S4.4, and thyroid hormones